Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
22.12
-0.17 (-0.76%)
At close: Dec 5, 2025, 4:00 PM EST
21.97
-0.15 (-0.68%)
After-hours: Dec 5, 2025, 7:00 PM EST
Pediatrix Medical Group Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Pediatrix Medical Group stock have an average target of 21, with a low estimate of 17 and a high estimate of 24. The average target predicts a decrease of -5.06% from the current stock price of 22.12.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pediatrix Medical Group stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 5 | 5 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 7 | 7 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $17 → $24 | Hold | Maintains | $17 → $24 | +8.50% | Nov 10, 2025 |
| UBS | UBS | Hold Maintains $17 → $23 | Hold | Maintains | $17 → $23 | +3.98% | Nov 5, 2025 |
| Leerink Partners | Leerink Partners | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | -23.15% | Sep 5, 2025 |
| UBS | UBS | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | -25.41% | Aug 14, 2025 |
| UBS | UBS | Hold Maintains $19 → $16 | Hold | Maintains | $19 → $16 | -27.67% | May 12, 2025 |
Financial Forecast
Revenue This Year
1.96B
from 2.01B
Decreased by -2.43%
Revenue Next Year
2.02B
from 1.96B
Increased by 2.70%
EPS This Year
2.15
from -1.19
EPS Next Year
2.25
from 2.15
Increased by 4.96%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.0B | 2.1B | |||
| Avg | 2.0B | 2.0B | |||
| Low | 1.8B | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3% | 8.2% | |||
| Avg | -2.4% | 2.7% | |||
| Low | -8.2% | -6.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.27 | 2.51 | |||
| Avg | 2.15 | 2.25 | |||
| Low | 2.01 | 2.07 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 16.9% | |||
| Avg | - | 5.0% | |||
| Low | - | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.